Title : Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms.

Pub. Date : 2013

PMID : 24302978






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The glucagon-like peptide-1 (GLP-1) enhancer, sitagliptin, reduces hyperglycemia but may also trigger direct effects on the heart. Sitagliptin Phosphate glucagon Rattus norvegicus
2 The glucagon-like peptide-1 (GLP-1) enhancer, sitagliptin, reduces hyperglycemia but may also trigger direct effects on the heart. Sitagliptin Phosphate glucagon Rattus norvegicus
3 CONCLUSIONS: Sitagliptin, via GLP-1 stabilization, promoted cardioprotection in type-II diabetic hearts primarily by limiting hyperglycemia e hyperlipidemia. Sitagliptin Phosphate glucagon Rattus norvegicus